Regeneron Antibody Cocktail Used by Trump Faces Patent Suit
U.S. President Donald Trump gestures outside of Walter Reed National Military Medical Center in Bethesda, Maryland, U.S. (Photographer: Chris Kleponis/Polaris/Bloomberg)

Regeneron Antibody Cocktail Used by Trump Faces Patent Suit

(Bloomberg) -- The Regeneron Pharmaceuticals Inc. “antibody cocktail” given to President Donald Trump to treat his Covid-19 symptoms was developed with the unauthorized use of a fluorescent protein...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.